Company Quick10K Filing
Quick10K
Oragenics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.41 46 $19
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-12-04 Regulation FD, Exhibits
8-K 2019-12-02 Other Events, Exhibits
8-K 2019-09-30 Regulation FD, Exhibits
8-K 2019-09-25 Other Events, Exhibits
8-K 2019-09-23 Regulation FD, Exhibits
8-K 2019-09-06 Regulation FD, Exhibits
8-K 2019-06-20 Shareholder Vote, Exhibits
8-K 2019-03-21 Enter Agreement, Other Events, Exhibits
8-K 2019-03-21 Other Events, Exhibits
8-K 2019-03-20 Other Events, Exhibits
8-K 2019-03-15 Other Events, Exhibits
8-K 2019-02-22 Officers
8-K 2018-12-19 Officers
8-K 2018-12-03 Regulation FD, Exhibits
8-K 2018-10-17 Other Events, Exhibits
8-K 2018-10-03 Other Events
8-K 2018-09-27 Officers, Other Events, Exhibits
8-K 2018-09-25 Other Events, Exhibits
8-K 2018-08-15 Regulation FD, Other Events, Exhibits
8-K 2018-07-13 Enter Agreement, Amend Bylaw, Other Events, Exhibits
8-K 2018-06-22 Officers, Amend Bylaw, Shareholder Vote, Exhibits
8-K 2018-06-06 Enter Agreement, Officers, Exhibits
8-K 2018-05-30 Other Events, Exhibits
8-K 2018-05-23 Other Events, Exhibits
8-K 2018-04-06 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-01-19 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2018-01-08 Other Events, Exhibits

Oragenics Financials

-

OGEN Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comparables ($'000 Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Sophiris Bio SPHS 22,965 6,441 8,817 0 0 -1,876 -1,117 24,643
Prophase Labs PRPH 24,276 15,799 1,147 10,501 2,878 -3,775 -2,642 23,076
Clearside Biomedical CLSD 37,369 29,854 16,953 90 0 -66,648 -66,447 20,934
Citius Pharmaceuticals CTXR 21,414 25,545 4,038 0 0 -14,759 -14,743 16,903
Aytu Bioscience AYTU 31,744 34,721 27,634 8,145 5,943 -27,132 -25,416 20,450
Azurrx Biopharma AZRX 36,087 9,612 6,664 0 0 -16,295 -15,002 34,776
Evoke Pharma EVOK 12,780 7,631 1,285 0 0 -7,359 -7,359 5,340
Oncosec Medical ONCS 19,912 26,993 5,816 0 0 -32,728 -32,472 -2,346
Aileron Therapeutics ALRN 18,700 40,193 10,209 0 0 -28,853 -28,659 -12,822
Heat Biologics HTBX 24,528 29,703 7,747 4,942 0 -18,643 -19,144 5,028
Soligenix SNGX 14,243 9,193 5,557 5,086 946 -8,730 -9,294 7,257
Oragenics OGEN 23,062 26,933 2,510 0 0 -13,646 -13,594 -2,657
Atossa Genetics ATOS 18,533 18,609 1,057 0 0 -16,724 -16,670 1,364
Fibrocell Science FCSC 21,874 34,856 16,993 0 16,620 3,595 5,374 8,199
Flex Pharma FLKS 9,577 7,137 1,036 684 433 -8,262 -8,262 3,063
Adial Pharmaceuticals ADIL 19,973 10,687 627 0 0 -14,277 -14,277 9,719
Xenetic Biosciences XBIO 7,682 15,633 5,242 0 0 -6,156 -6,156 6,648
Pulmatrix PULM 18,447 37,047 18,955 4,819 0 -22,154 -21,946 -13,574
ESSA Pharma EPIX 17,617 16,017 6,865 0 0 0 0 17,617
MYOS RENS MYOS 13,939 4,519 1,265 518 219 -3,126 -3,111 12,781

Balance Sheet ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash9,9268,3506,3688,26816,27714,63912,89911,76510,4499,0538,0446,7395,0833,3685,4575,1174,0812,1752,0892,9236,1664,7583,94113,81120,20829,34925,720
Accounts Receivable70555059644323261630271921330
Inventory124117303223288266239264439377364299322241000
PP&E1,5386449381,5573932261,6661681711591,5891221041071,6066952341,6061411641,731104102
Assets10,4888,8237,0718,81516,83115,14113,33712,30311,1329,7618,6957,3905,7783,9576,1375,3964,3092,3514,5775,1357,2155,4945,20915,53622,05031,30926,933
Accounts Payable440249484384461618829
Long-Term Debt
Liabilities1,2561,1741,3884,4539939387787407966065,6015,8871,0471,0838989091,3431,1654,0724,1228991,1791,5581,5571,1682,1852,510
Stockholders' Equity9,2327,6495,6834,36215,83914,20312,55911,56410,3369,1563,0941,5034,7312,8745,2394,4862,9661,1865051,0136,3164,3153,65113,97920,88229,12424,423
Income Statement ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue431176168253435215304201221364242330240262000000000
Cost of Revenue6487113801267491168871359000
Gross Profit1128114013517812713019615519517200
R&D7456376,9071,0691,0169035975486775,6121,1711,2418139251,1226059968151,3261,6011,5811,7942,4143,879
SG&A1,1031,5192,5587671,177565812815874854994921
Tax00000000000000000000000
Net Income-1,989-1,590-2,074-9,325-3,079-1,641-1,896-1,030-1,224-1,293-6,335-1,864-2,219-2,063-313-1,963-2,675-1,983-529-2,067-1,461-2,119-2,281-2,758-2,756-3,326-4,806
Cash Flow ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-1,581-2,000-1,964-1,571-1,900-1,765-1,340-1,359-1,367-2,281-2,454-2,978-2,211-3,488
Cash Investing-11425-64
Cash Financing5243,876950-51,6792,1744,601-421,46312,3869,43911,351-130